covid vaccine in the country and also manufacturing of the vaccine in the country, said Dr VK Paul, member (health) of NITI Aayog.The Indian government of India attaches great importance to this offer of partnership from a very special friend of this nation, and on both the tracks there has been significant movement, he said.Dr Paul heads the National Expert Group on Vaccine Administration for COVID-19.In August, Russia had registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, after completing early-stage human trials.The Sputnik V vaccine is currently undergoing Phase 3 trials in Russia.
The Sputnik V vaccine produced an antibody response in all participants in early-stage trials, according to results published.